|
Report No. : |
332298 |
|
Report Date : |
16.07.2015 |
IDENTIFICATION DETAILS
|
Name : |
MEDICOS HIRATA INC |
|
|
|
|
Registered Office : |
3-3-18 Dojima Kitaku Osaka |
|
|
|
|
Country : |
Japan |
|
|
|
|
Financials (as on) : |
30.09.2014 |
|
|
|
|
Date of Incorporation : |
October 1950 |
|
|
|
|
Com. Reg. No.: |
1200-01-07231 |
|
|
|
|
Legal Form : |
Limited Company |
|
|
|
|
Line of Business : |
Imports, exports and wholesales medical devices,
other (--100%) |
|
|
|
|
No. of Employees : |
231 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
Yen 397.8 Million |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
Japan |
A1 |
A1 |
|
Risk Category |
ECGC Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
JAPAN - ECONOMIC OVERVIEW
In the years following World War II, government-industry cooperation,
a strong work ethic, mastery of high technology, and a comparatively small
defense allocation (1% of GDP) helped Japan develop an advanced economy. Two
notable characteristics of the post-war economy were the close interlocking
structures of manufacturers, suppliers, and distributors, known as keiretsu,
and the guarantee of lifetime employment for a substantial portion of the urban
labor force. Both features are now eroding under the dual pressures of global
competition and domestic demographic change. Scarce in many natural resources,
Japan has long been dependent on imported raw materials. Since the complete
shutdown of Japan’s nuclear reactors after the earthquake and tsunami disaster
in 2011, Japan's industrial sector has become even more dependent than it was
previously on imported fossil fuels. A small agricultural sector is highly
subsidized and protected, with crop yields among the highest in the world.
While self-sufficient in rice production, Japan imports about 60% of its food
on a caloric basis. For three decades, overall real economic growth had been
impressive - a 10% average in the 1960s, a 5% average in the 1970s, and a 4%
average in the 1980s. Growth slowed markedly in the 1990s, averaging just 1.7%,
largely because of the aftereffects of inefficient investment and an asset
price bubble in the late 1980s that required a protracted period of time for
firms to reduce excess debt, capital, and labor. Modest economic growth
continued after 2000, but the economy has fallen into recession four times
since 2008. Government stimulus spending helped the economy recover in late
2009 and 2010, but the economy contracted again in 2011 as the massive 9.0
magnitude earthquake and the ensuing tsunami in March of that year disrupted
manufacturing. The economy has largely recovered in the four years since the
disaster, although reconstruction in the affected Tohoku region has lagged, in
part due to a shortage of labor in the construction sector. Japan enjoyed a
sharp uptick in growth in 2013 on the basis of Prime Minister Shinzo Abe’s
“Three Arrows” economic revitalization agenda - dubbed “Abenomics” - of
monetary easing, “flexible” fiscal policy, and structural reform. Abe’s
government has replaced the preceding administration’s plan to phase out nuclear
power with a new policy of seeking to restart nuclear power plants that meet
strict new safety standards, and emphasizing nuclear energy’s importance as a
base-load electricity source. Japan joined the Trans-Pacific Partnership (TPP)
negotiations in 2013, a pact that would open Japan's economy to increased
foreign competition and create new export opportunities for Japanese
businesses. Measured on a purchasing power parity (PPP) basis that adjusts for
price differences, Japan in 2014 stood as the fourth-largest economy in the
world after second-place China, which surpassed Japan in 2001, and third-place
India, which edged out Japan in 2012. While seeking to stimulate and reform the
economy, the government must also devise a strategy for reining in Japan's huge
government debt, which amounts to more than 230% of GDP. To help raise
government revenue, Japan adopted legislation in 2012 to gradually raise the
consumption tax rate to 10% by 2015, beginning with a hike from 5% to 8%
implemented in April 2014. That increase had a contractionary effect on GDP,
however, so PM Abe in late 2014 decided to postpone the final phase of the
increase until April 2017 to give the economy more time to recover. Led by the
Bank of Japan’s aggressive monetary easing, Japan is making progress in ending
deflation, but demographics - low birthrate and an aging, shrinking population
- pose major long-term challenges for the economy.
|
Source
: CIA |
MEDICOS HIRATA INC
REGD NAME: KK
Medicos Hirata
MAIN OFFICE: 3-4-3
Edobori Nishiku Osaka550-0002 JAPAN
Tel: 06-6443-9502 Fax: 06-5443-2333
*.. The is its
Sakai Laboratory
**.. Registered
at: 3-3-18 Dojima Kitaku Osaka
URL: http://www.medico-hirata.co.jp
E-Mail address: (thru the URL)
ACTIVITIES: Import,
export, wholesale of medical devices (X-rays, circulatory organs, other)
BRANCHES: Tokyo,
Sapporo, Sendai, Yokohama, Nagoya, Kanazawa, other (Tot 12)
OVERSEAS: USA
OFFICERS: MASATAKA
HIRATA, PRES Yuriko Hirata, s/mgn
dir
Yasuhiro Hirata,
ch Toshiyuki Yamada,
mgn dir
Yen Amount: In million Yen, unless otherwise stated
FINANCES FAIR A/SALES Yen 6,843 M
PAYMENTS NO COMPLAINTS CAPITAL Yen
70 M
TREND SLOW WORTH Yen 11,341 M
STARTED 1950 EMPLOYES 231
COMMENT: TRADING FIRM SPECIALIZING IN MEDICAL DEVICES. FINANCIAL SITUATION CONSIDERED FAIR AND GOOD FOR ORDINARY BUSINESS ENGAGEMENTS.
MAX CREDIT LIMIT: ESTIMATED AT YEN 397.8 MILLION, ON 30 DAYS NORMAL TERMS.
The subject company is an old-established company dating back to 1918 and was incorporated in 1950. Masataka Hirata took the pres office in Jun 2002. This is a trading firm specializing in import, export and wholesale of medical devices (X-rays, circulatory organs, other). Goods are imported from USA, Germany, France, other. Clients include hospitals, laboratories, mfrs, other.
The sales volume for Sept/2014 fiscal term amounted to Yen 6,843 million, a 14% down from Yen 8,000 million in the previous term. The recurring profit was posted at Yen 216 million and the net profit at Yen 106 million, respectively, compared with Yen 794 million recurring profit and Yen 508 million net profit, respectively, a year ago.
For the current term ending Sept 2015 the recurring profit is projected at Yen 230 million and the net profit at Yen 115 million, respectively, on a 5% rise in turnover, to Yen 7,200 million.
The financial situation is considered FAIR and good for ORDINARY business engagements. Max credit limit is estimated at Yen 397.8 million, on 30 days normal terms.
Date Registered: Oct 1950
Regd No.:
1200-01-07231
(Osaka-Kitaku)
Legal Status: Limited
Company (Kabushiki Kaisha)
Authorized: 560,000 shares
Issued: 140,000
shares
Sum: Yen
70 million
Major
shareholders (%): Yasuhiro Hirata (54), Masataka Hirata (30), Yuriko Hirata
(5)
No.
of shareholders: 7
Nothing
detrimental is known as to the commercial morality of executives.
Activities: Imports, exports
and wholesales medical devices, other (--100%)
Clients: [Mfrs,
wholesalers] Miyano Medical Instruments, Yagami Co, Daikoku Medical, Mutou
Group firms, Konishi Medical Instruments, Yamashita Total Medical Support, ITI,
other
No. of accounts:
500
Domestic areas of
activities: Nationwide
Suppliers: [Mfrs,
wholesalers] Penumbra Inc (USA), Peruse Midical (France), Medi-Globe GmbH
(Germany), Kaneka Medix Corp, other
Payment record: No Complaints
Location: Business area in
Osaka. Office premises at the caption
address are owned and maintained satisfactorily.
Bank References:
SMBC (Dojima)
MUFG (Nakanoshima)
Relations:
Satisfactory
(In
Million Yen)
|
Terms Ending: |
30/09/2015 |
30/09/2014 |
30/09/2013 |
30/09/2012 |
|
|
Annual
Sales |
|
7,200 |
6,843 |
8,000 |
9,784 |
|
Recur.
Profit |
|
230 |
216 |
794 |
1,351 |
|
Net
Profit |
|
115 |
106 |
508 |
766 |
|
Total
Assets |
|
|
11,974 |
17,079 |
12,000 |
|
Current
Assets |
|
|
10,854 |
10,912 |
10,862 |
|
Current
Liabs |
|
|
533 |
737 |
1,161 |
|
Net
Worth |
|
|
11,341 |
11,241 |
10,739 |
|
Capital,
Paid-Up |
|
|
70 |
70 |
70 |
|
Div.P.Share(¥) |
|
|
0.00 |
0.00 |
0.00 |
|
<Analytical Data> |
|
(%) |
(%) |
(%) |
(%) |
|
S.Growth Rate |
|
5.22 |
-14.46 |
-18.23 |
67.88 |
|
Current Ratio |
|
.. |
2,036.40 |
1,480.60 |
935.57 |
|
N.Worth Ratio |
|
.. |
94.71 |
65.82 |
89.49 |
|
R.Profit/Sales |
|
3.19 |
3.16 |
9.93 |
13.81 |
|
N.Profit/Sales |
|
1.60 |
1.55 |
6.35 |
7.83 |
|
Return On Equity |
|
.. |
0.93 |
4.52 |
7.13 |
Notes: Forecast
(or estimated) figures for the 30/09/2015 fiscal term.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.63.38 |
|
|
1 |
Rs.99.13 |
|
Euro |
1 |
Rs.69.69 |
INFORMATION DETAILS
|
Analysis Done by
: |
KAS |
|
|
|
|
Report Prepared
by : |
TPT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.